13F filer · CIK 1457320 ↗
Exchange Traded Concepts, LLC
You are looking at Q4 2020. See the latest, Q3 2026 →
Reported value
$2.15B
+22% on the quarter before
Positions
990
302 new · 240 sold out
Top 10
42.5%
of the value
Est. gain
+$83.8M
on stocks held all quarter
Est. return
+12.4%
on those stocks since Q3 2020
Positions as of Dec 31, 2020, from Exchange Traded Concepts, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 59% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2020. Striped tiles are options.
Largest buys
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Select Sector SPDR Tr~$120.4MNew · 0.0% → 5.6%+748,790 shares
- Ishares Tr~$110.1MNew · 0.0% → 5.1%+697,798 shares
- Ishares Tr~$108.6MNew · 0.0% → 5.0%+786,066 shares
- Ishares Tr~$94.9MNew · 0.0% → 4.4%+2,464,520 shares
- Ishares Tr~$84.2MAdded · 0.9% → 4.7%+964,923 shares
- Ishares Tr~$80.8MNew · 0.0% → 3.8%+943,835 shares
- Vanguard Index Fds~$79.9MNew · 0.0% → 3.7%+671,267 shares
- Select Sector SPDR Tr~$79.4MNew · 0.0% → 3.7%+896,612 shares
- Select Sector SPDR Tr~$61.6MNew · 0.0% → 2.9%+473,436 shares
- Select Sector SPDR Tr~$41.0MAdded · 0.9% → 2.7%+361,045 shares
Largest sells
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Scottsdale Fds~$103.1MSold out · 5.8% → 0.0%−1,661,082 shares
- Invesco Db Us Dlr Index Tr~$95.2MCut · 5.8% → 0.1%−3,927,101 shares
- Vanguard Bd Index Fds~$87.1MSold out · 4.9% → 0.0%−1,048,955 shares
- Vanguard Charlotte Fds~$79.7MSold out · 4.5% → 0.0%−1,369,907 shares
- Vanguard World Fds~$76.4MCut · 4.1% → 0.0%−556,518 shares
- Vanguard Intl Equity Index F~$71.6MSold out · 4.0% → 0.0%−1,654,993 shares
- Ishares Tr~$70.7MSold out · 4.0% → 0.0%−1,684,038 shares
- Vanguard Scottsdale Fds~$65.1MSold out · 3.7% → 0.0%−923,699 shares
- Vanguard World Fds~$52.7MCut · 2.7% → 0.0%−235,430 shares
- SPDR Gold Tr~$47.2MSold out · 2.7% → 0.0%−266,363 shares
Holdings
As of Dec 31, 2020. Changes are in shares against Sep 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Select Sector SPDR TrSBI CONS DISCR · shares New | 5.6% | $120.4M | — | ||||||||
| Ishares Tr20 YR TR BD ETF · shares New | 5.1% | $110.1M | — | ||||||||
| Ishares TrIBOXX INV CP ETF · shares New | 5.0% | $108.6M | — | ||||||||
| Ishares TrIBOXX HI YD ETF · shares +502% · price +4.1% | 4.7% | $101.0M | +$653,014 | ||||||||
| Ishares TrPFD AND INCM SEC · shares New | 4.4% | $94.9M | — | ||||||||
| Ishares TrU.S. REAL ES ETF · shares New | 3.8% | $80.8M | — | ||||||||
| Invesco Qqq TrUNIT SER 1 · shares −32% · price +12.9% | 3.7% | $80.1M | +$9.2M | ||||||||
| Vanguard Index FdsMCAP VL IDXVIP · shares New | 3.7% | $79.9M | — | ||||||||
| Select Sector SPDR TrSBI INT-INDS · shares New | 3.7% | $79.4M | — | ||||||||
| Select Sector SPDR TrTECHNOLOGY · shares New | 2.9% | $61.6M | — | ||||||||
| Select Sector SPDR TrSBI HEALTHCARE · shares +232% · price +7.5% | 2.7% | $58.6M | +$1.2M | ||||||||
| Select Sector SPDR TrSBI INT-UTILS · shares New | 1.7% | $37.5M | — | ||||||||
| SPDR Ser TrS&P DIVID ETF · shares New | 1.7% | $37.0M | — | ||||||||
| Select Sector SPDR TrSBI CONS STPLS · shares New | 1.7% | $37.0M | — | ||||||||
| Invesco Exchange Traded Fd TFINL PFD ETF · shares +1,516% · price +2.5% | 1.7% | $36.5M | +$55,457 | ||||||||
| Ishares TrRUS MDCP VAL ETF · shares New | 1.1% | $24.5M | — | ||||||||
| Vanguard Index FdsGROWTH ETF · shares New | 1.1% | $24.4M | — | ||||||||
| SPDR S&P 500 ETF TrTR UNIT · shares −10% · price +11.6% | 0.85% | $18.4M | +$1.9M | ||||||||
| AmazonCOM · shares +5.6% · price +3.4% | 0.75% | $16.2M | +$510,659 | ||||||||
| Verizon Communications IncCOM · shares +8.4% · price −1.2% | 0.71% | $15.4M | −$178,722 | ||||||||
| Philip Morris Intl IncCOM · shares +27% · price +10.4% | 0.65% | $14.0M | +$1.0M | ||||||||
| IBMCOM · shares +48% · price +3.5% | 0.57% | $12.3M | +$276,872 | ||||||||
| Nike IncCL B · shares +106% · price +12.7% | 0.54% | $11.6M | +$637,475 | ||||||||
| Penn Natl Gaming IncCOM · shares +16% · price +18.8% | 0.50% | $10.8M | +$1.5M | ||||||||
| Eli LillyCOM · shares −12% · price +14.1% | 0.49% | $10.6M | +$1.3M | ||||||||
| Total · 990 positions | 100% | $2.15B | +$83.8M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2020 to Q4 2020: 686 stocks held throughout, up $83.8M (+12.4%).
- Invesco Qqq Tr+$9.2M+13%
- SPDR S&P 500 ETF Tr+$1.9M+12%
- Metlife Inc+$1.8M+26%
- Abbvie Inc+$1.7M+22%
- Penn Natl Gaming Inc+$1.5M+19%
- Crispr Therapeutics Ag1:18 split−$409,801−90%
- Gilead Sciences Inc−$420,845−8%
- Qiwi Plc−$920,900−41%
- Biogen Inc−$1.4M−14%
- Draftkings Inc−$1.9M−21%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | $25.28B+16% | SEC ↗ |
| Q2 2026 | Aug 11, 2026 (amended) | $21.88B+55% | SEC ↗ |
| Q1 2026 | Apr 15, 2026 | $14.12B+7% | SEC ↗ |
| Q4 2025 | Jan 14, 2026 | $13.14B+12% | SEC ↗ |
| Q3 2025 | Oct 14, 2025 | $11.76B+44% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $8.18B+40% | SEC ↗ |
| Q1 2025 | Apr 17, 2025 | $5.84B+16% | SEC ↗ |
| Q4 2024 | Jan 21, 2025 | $5.03B+18% | SEC ↗ |
| Q3 2024 | Oct 10, 2024 | $4.28B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.96B+2% | SEC ↗ |
| Q1 2024 | Apr 15, 2024 | $3.88B+4% | SEC ↗ |
| Q4 2023 | Jan 5, 2024 | $3.74B+6% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $3.53B−13% | SEC ↗ |
| Q2 2023 | Jul 20, 2023 | $4.06B+11% | SEC ↗ |
| Q1 2023 | Apr 12, 2023 | $3.65B+5% | SEC ↗ |
| Q4 2022 | Jan 27, 2023 (amended) | $3.49B+14% | SEC ↗ |
| Q3 2022 | Oct 7, 2022 | $3.06B−11% | SEC ↗ |
| Q2 2022 | Jul 20, 2022 | $3.44B−31% | SEC ↗ |
| Q1 2022 | Apr 26, 2022 | $4.98B−3% | SEC ↗ |
| Q4 2021 | Jan 13, 2022 | $5.16B+32% | SEC ↗ |
| Q3 2021 | Oct 18, 2021 | $3.92B+24% | SEC ↗ |
| Q2 2021 | Jul 30, 2021 | $3.16B+18% | SEC ↗ |
| Q1 2021 | Apr 20, 2021 | $2.67B+24% | SEC ↗ |
| Q4 2020 | Jan 19, 2021 | $2.15B+22% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $1.77B+193% | SEC ↗ |
| Q2 2020 | Jul 15, 2020 | $602.9M+226% | SEC ↗ |
| Q1 2020 | Apr 14, 2020 | $184.9M−61% | SEC ↗ |
| Q4 2019 | Jan 22, 2020 | $478.5M | SEC ↗ |